Ibrutinib/Lenalidomide/Rituximab Regimen

Preferred Label : Ibrutinib/Lenalidomide/Rituximab Regimen;

NCIt synonyms : Ibrutinib/Rituximab/Lenalidomide; Rituximab/Ibrutinib/Lenalidomide; Ibrutinib/Lenalidomide/Rituximab; Ibrutinib-Lenalidomide-Rituximab; Imbruvica/Revlimid/Rituxan;

NCIt definition : A regimen consisting of ibrutinib, lenalidomide and rituximab that may be used in the treatment of mantle cell lymphoma.;

NCI Metathesaurus CUI : CL1905741;

Détails

Origin ID

C198550;

UMLS CUI

C5854960;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Ibrutinib [NCIt concept]
- Lenalidomide [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients